2273. Azithromycin Use Before and During COVID- 19 and Impact of Implementing Evidence-based Guidelines

BACKGROUND: Early in the COVID-19 pandemic, results from small uncontrolled studies led to azithromycin being proposed as an effective treatment in patients with COVID-19. Numerous subsequent randomized controlled trials and observational studies have failed to demonstrate azithromycin’s effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Shams, Sherin, Nafady-Hego, Hanaa, Thomas, Anil G, Saleem, Samah, Hanana, Fathima, Malik, Aimon, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Umar, Aftab Mohammad, Alkhal, Abdullatif, Almaslamani, Muna, Abou-Samra, Abdul-Badi, Butt, Adeel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678686/
http://dx.doi.org/10.1093/ofid/ofad500.1895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678686/
http://dx.doi.org/10.1093/ofid/ofad500.1895

Ejemplares similares